![Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies - ScienceDirect Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009279714001264-fx1.jpg)
Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies - ScienceDirect
![Frontiers | The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study | Pharmacology Frontiers | The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study | Pharmacology](https://www.frontiersin.org/files/Articles/469420/fphar-10-00908-HTML/image_m/fphar-10-00908-g001.jpg)
Frontiers | The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study | Pharmacology
![Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study | Annals of the Rheumatic Diseases Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/70/7/1264/F3.large.jpg)
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study | Annals of the Rheumatic Diseases
![Cancers | Free Full-Text | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles | HTML Cancers | Free Full-Text | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles | HTML](https://www.mdpi.com/cancers/cancers-12-00144/article_deploy/html/images/cancers-12-00144-ag.png)
Cancers | Free Full-Text | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles | HTML
![GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout | The Journal of Immunology GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/205/12/3300/F3.medium.gif)
GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout | The Journal of Immunology
![Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5710422a-7b47-4eeb-ac52-48a5a375394e/gr1_lrg.jpg)
Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents
![Is it time to introduce anti-inflammatory drugs into secondary cardiovascular prevention: evidence from clinical trials? Is it time to introduce anti-inflammatory drugs into secondary cardiovascular prevention: evidence from clinical trials?](https://oaepublishstorage.blob.core.windows.net/0f515c1e-6a9c-4191-aa4d-dec70b610ef4/3942.fig.1.jpg)
Is it time to introduce anti-inflammatory drugs into secondary cardiovascular prevention: evidence from clinical trials?
![Frontiers | NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments | Pharmacology Frontiers | NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments | Pharmacology](https://www.frontiersin.org/files/Articles/708302/fphar-12-708302-HTML/image_m/fphar-12-708302-g001.jpg)